EMA Public Support for Mobilise-D: Follow-up

In the first year of Mobilise-D, we asked the European Medicines Agency (EMA) for Qualification Advice regarding Digital Mobility Outcomes (DMOs). EMA published their first letter of support in April 2020 that publicly endorsed our initial stage in the wider objective of the Mobilise-D consortium to pursue the qualification of Digital Mobility Outcomes (DMOs) as…

Episode 3: Making a difference in people’s lives – Silvia Del Din awarded a NUAcT Fellowship.

Our Mobilise-D colleague Dr. Silvia Del-Din has always been fascinated by research and the idea of “making a difference in people’s lives”. Here she explains her role in Mobilise-D, her new NUAcT fellowship at Newcastle University, and her perspective on how remote monitoring can revolutionize healthcare.  Silvia (37) was born in Agordo in the North-East of Italy and is a great fan of travelling and hiking. In her professional life, she has been involved in research for more than 10 years now. But how did a young girl from a small town nestled in the Dolomites, end up doing…

Key challenges in the use & development of digital endpoints from a health technology assessment (HTA) perspective

Digital endpoints offer a great potential to be considered in the HTA framework. So far, however, there is no institutional way in.  On February 15, 2021, IMI Neuronet hosted an online meeting of its working group on health technology assessment (HTA) and regulatory interactions, moderated by Diana O’Rourke from the National Institute for Health and Care Excellence (NICE). The discussions were based around the experiences of three different IMI projects that are…

Neuronet ECR submission for the virtual Alzheimer Europe Conference is open!

Neuronet invites Early Career Researchers from the Innovative Medicines Initiative’s neurodegeneration research projects to present their work at the upcoming Alzheimer Europe Conference.Applicants whose abstracts are accepted for a Quick Oral or Poster presentation will be granted a free registration to attend the three-day virtual conference. The deadline for submissions is June 30. This will…

IMI article about our Digital Health Catalyst initiative

The Digital Health Catalyst (DHC) was created by Mobilise-D and IDEA-FAST in response to the growing need for research and application in the area of real-world digital measurements. “The field will require a new generation of personnel from areas including clinical research and application, sensor and hardware development, infrastructure and data handling, data processing and…

When life gives you lemons, make Lemon Drizzle cake!

Real World Stories – Episode 3: “My balance is elusive advanced Multiple Sclerosis (MS). Always optimistic. Want to walk at least 25 times a month for eight months #2021Walkathon. Love my Travelscoot (The Trike)”. This is the Twitter bio of “Patrick Burke, I walk very slowly”, the inspiration behind the third episode of our Real World Stories.   Patrick (68) is happily married and has three children in their 30s. He is medically…

Mobilise-D and IDEA-FAST announce the creation of the Digital Health Catalyst (DHC)

Mobilise-D and IDEA-FAST are pleased to announce the creation of the Digital Health Catalyst (DHC). Mobilise-D is working on digital mobility assessment in chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), multiple sclerosis (MS) and recovery from proximal femoral fracture (PFF). IDEA-FAST is working to identify digital endpoints to assess fatigue, sleep disturbances and activities…